Under construction – not a live service
Sign in
Taking peopleNo phase

Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES

Key facts

Who runs it
Centre Hospitalier Universitaire de la Guadeloupe
Where
Guadeloupe1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
10 people, planned
Started
16 Jul 2021
Expected to end
16 Jul 2029
Type of study
Observational
Record updated
5 December 2025

Who can take part

Age
16 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patient with a diagnosis of dermatomyositis according to the 2003 ENMC criteria
  • Patient with parents or grandparents originating from the Caribbean arc
  • Patient aged 16 years or older
  • Patient residing in Guadeloupe
  • Patient (or legal representative) who has received information about the study and has signed the informed consent form
  • Patient affiliated with a social security scheme

Who cannot take part

  • Patient who started treatment with intravenous immunoglobulins, corticosteroids, or immunosuppressants within the month prior to the diagnosis of dermatomyositis
  • Patient under legal protection (guardianship or trusteeship) or deprived of liberty

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Dermatomyositis is a rare chronic autoimmune and inflammatory disease that affects the skin and striated muscles. Its prognosis is linked to visceral involvement (lungs, heart, and oropharyngeal region) and to the possible presence of associated cancer. The implementation of the research will allow identification of incident cases of dermatomyositis in Guadeloupe and the characterization of the disease in the overseas population, in the absence of data in the literature.

The group in the trial

  • Patients with dermatomyositis

    All patient with dermatomyositis

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
5 December 2025